Anal Stretch (Lord's Procedure) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Anal stretch, formally known as Lord's procedure or manual anal dilation, is a surgical technique originally described by Dr. Peter Lord in 1968 for the treatment of hemorrhoids and later applied to chronic anal fissures. The procedure involves systematic dilation of the anal canal under anesthesia to stretch and disrupt the fibers of the hypertonic internal anal sphincter, thereby reducing the elevated resting anal pressure that perpetuates anal fissures and contributes to hemorrhoidal symptoms.

Chronic anal fissure is one of the most common anorectal conditions, affecting approximately 11% of the general population during their lifetime. The condition develops when elevated internal anal sphincter tone reduces blood flow to the posterior midline of the anal canal, creating ischemia that prevents healing of the mucosal tear. By reducing sphincter hypertonicity, anal stretch aims to restore normal blood flow and allow fissure healing. Hemorrhoids, affecting roughly 50% of adults by age 50, may also benefit from reduced sphincter pressure.

While historically popular due to its simplicity and effectiveness, anal stretch has seen declining use over recent decades as concerns about unpredictable sphincter injury and associated incontinence rates have led to the development of more targeted treatments. Modern anorectal surgery favors lateral internal sphincterotomy for surgical management and topical pharmacological agents (glyceryl trinitrate, diltiazem, botulinum toxin) as first-line therapies. Nevertheless, understanding this procedure remains relevant as modified versions continue to be practiced in certain clinical contexts.

Anal stretch has been used to treat several anorectal conditions characterized by internal anal sphincter hypertonicity or tightness of the anal canal. The primary indications include:

• Chronic anal fissure: A persistent tear in the lining of the anal canal that has not healed with conservative measures (dietary fiber, stool softeners, topical nitroglycerin) for 6-8 weeks. The procedure reduces elevated sphincter tone to improve blood flow and promote healing.
• Internal hemorrhoids (Grade I-III): Lord originally described the procedure for hemorrhoids, combining dilation with manual repositioning of prolapsed hemorrhoidal tissue. Reduced sphincter tone decreases venous congestion that contributes to hemorrhoidal swelling.
• Anal stenosis: Narrowing of the anal canal from scarring, previous surgery, inflammatory bowel disease, or radiation therapy. Controlled dilation can gradually widen the stenotic segment.
• Proctalgia fugax: Episodes of severe rectal pain attributed to internal anal sphincter spasm, though evidence for dilation in this condition is limited.
• Postoperative anal stricture: Narrowing following hemorrhoidectomy or other anorectal procedures that limits bowel function and causes pain with defecation.

Candidates for anal stretch are patients with chronic anal fissures or anal stenosis who have failed conservative medical therapy, including dietary modifications, fiber supplementation, stool softeners, sitz baths, and topical pharmacological treatments (glyceryl trinitrate ointment, diltiazem cream, or botulinum toxin injection). The procedure may also be considered for patients who are unable to tolerate or have contraindications to lateral internal sphincterotomy.

Preoperative evaluation includes a careful anorectal examination to confirm the diagnosis, assess sphincter tone, and exclude other pathology. Anal manometry may be performed to document elevated resting anal pressures and assess sphincter function before and after treatment. Endoanal ultrasound can identify pre-existing sphincter defects that would increase the risk of incontinence from dilation. Patients with existing sphincter injury or pre-existing incontinence are generally not suitable candidates.

Contraindications include pre-existing fecal incontinence or sphincter dysfunction, prior sphincter injury (obstetric or surgical), inflammatory bowel disease with active perianal involvement (Crohn disease), suspected anal malignancy, anorectal abscess, and conditions requiring alternative surgical approaches such as fistula-in-ano. The procedure is used with caution in elderly patients and multiparous women, who may have reduced baseline sphincter function and are at higher risk of postoperative incontinence.

Lord's original technique involves inserting four to eight fingers (four from each hand) progressively into the anal canal under general anesthesia and maintaining maximal dilation for approximately 4 minutes. The goal is to stretch the internal anal sphincter sufficiently to reduce its resting tone by approximately 30-50%. The uncontrolled nature of this technique means that the extent of sphincter disruption varies significantly between patients and operators, which has been a primary criticism leading to inconsistent outcomes.

Controlled anal dilation is a modified approach that uses graduated dilators (such as Park's retractors or pneumatic balloon dilators) to achieve a more standardized and predictable degree of sphincter stretch. Balloon dilation, using a balloon inflated to a specific diameter (typically 40-50 mm) for a set duration (90 seconds to 6 minutes), provides more uniform stretch and has demonstrated fissure healing rates of 65-90% with lower incontinence rates than the original manual technique.

Staged dilation may be employed for anal stenosis, where the anal canal is progressively widened over multiple sessions using graduated Hegar dilators or bougie dilators. Patients may also be taught self-dilation techniques for home use between clinical sessions. This approach allows for gradual tissue adaptation and reduces the risk of uncontrolled sphincter injury.

Combined approaches pair dilation with adjunctive treatments such as botulinum toxin injection into the internal sphincter (to provide sustained chemical sphincter relaxation during healing) or application of topical treatments postoperatively. Fissurectomy (excision of the chronic fissure edges to promote fresh wound healing) may be combined with controlled dilation when scar tissue prevents fissure healing with sphincter relaxation alone.

The primary benefit of anal stretch is rapid reduction in internal anal sphincter tone, providing immediate relief of the sphincter spasm that drives pain and ischemia in chronic anal fissures. Fissure healing rates following anal dilation range from 65% to 90% in published series, with most healing occurring within 6-8 weeks postoperatively. Pain relief is often immediate, with significant reduction in postoperative anal pain compared to the chronic pain experienced before the procedure.

Compared to lateral internal sphincterotomy, anal stretch has the advantage of not creating a permanent structural defect in the sphincter muscle, as the stretch is intended to cause temporary disruption rather than permanent division of muscle fibers. The procedure is technically simple, requires no specialized instruments (in the manual technique), and has a shorter operative time (typically 5-10 minutes). There is no surgical wound requiring healing, which may translate to faster initial recovery compared to sphincterotomy.

For anal stenosis, graduated dilation can restore adequate anal canal caliber and improve bowel function, reducing pain with defecation and eliminating the need for more complex surgical reconstruction such as anoplasty. Self-dilation programs after initial treatment help maintain the achieved caliber and prevent restenosis. Patient satisfaction in anal stenosis treatment is generally high when adequate dilation is achieved and maintained.

The most significant risk of anal stretch is damage to the anal sphincter mechanism resulting in varying degrees of fecal incontinence. The original Lord's manual dilation technique has been associated with incontinence rates of 10-30% in some studies, ranging from minor incontinence to flatus (gas) to more significant impairment of solid or liquid stool control. This unpredictable sphincter injury is the primary reason the procedure has fallen out of favor compared to lateral internal sphincterotomy, which has incontinence rates of approximately 3-5%.

Sphincter damage from anal stretch can be detected on endoanal ultrasound as fragmentation of the internal anal sphincter ring. Unlike the controlled, localized division performed in sphincterotomy, manual dilation causes irregular disruption of sphincter fibers that may extend to the external sphincter in severe cases. The risk of significant sphincter injury is higher with more forceful dilation, longer duration of stretch, and in patients with pre-existing sphincter weakness.

Other complications include mucosal tears and bleeding (usually minor and self-limiting), perianal hematoma, thrombosis of external hemorrhoids, recurrence of the original condition (fissure recurrence rates of 10-20% over long-term follow-up), and rarely, pelvic sepsis from deep mucosal tears. Chronic perianal pain or dysesthesia may occasionally persist after the procedure. Anal stenosis from excessive scarring is a rare late complication.

Anal stretch is typically performed as a day-case procedure, with patients discharged on the same day once they have recovered from anesthesia. Immediate postoperative discomfort is usually mild and well-managed with oral analgesics (paracetamol, ibuprofen) and avoidance of opioids which can cause constipation. Warm sitz baths (sitting in warm water for 15-20 minutes) 2-3 times daily are recommended for the first 1-2 weeks to promote comfort and hygiene.

Stool softeners and fiber supplementation are prescribed for 4-8 weeks to ensure soft, formed stools that pass without straining, which is essential for fissure healing and sphincter recovery. Patients are advised to maintain adequate fluid intake (2-3 liters daily), follow a high-fiber diet, and avoid straining during bowel movements. Most patients can return to normal daily activities within 3-7 days, with full recovery and fissure healing expected within 4-8 weeks.

Follow-up visits are typically scheduled at 2-4 weeks and 6-8 weeks postoperatively to assess fissure healing, evaluate sphincter function, and address any continence concerns. If fissure healing is incomplete, additional treatments such as topical nitrate ointment or botulinum toxin injection may be recommended. Long-term follow-up is important to monitor for recurrence (which occurs in 10-20% of patients) and to detect any delayed onset of incontinence symptoms. Patients experiencing any degree of incontinence should be referred for anorectal physiology testing and specialist management.

Anal stretch is generally one of the less expensive anorectal surgical procedures due to its short operative time, minimal equipment requirements, and day-case nature. Cost factors include the type of anesthesia used (general versus regional), the surgical facility setting (office-based procedure suite versus ambulatory surgery center versus hospital), surgeon's fees, and any preoperative diagnostic testing such as anal manometry or endoanal ultrasound.

When performed as a controlled balloon dilation, the cost of the disposable balloon catheter adds to the procedure expense. Additional costs may include preoperative consultations, pathology fees if tissue is excised (fissurectomy), and postoperative medications (stool softeners, topical treatments, analgesics). Patients requiring multiple staged dilation sessions for anal stenosis will incur cumulative facility and professional fees.

Most health insurance plans cover anal stretch when it is performed for a documented medical indication (chronic anal fissure unresponsive to conservative treatment, anal stenosis). The procedure is considered medically necessary rather than cosmetic, so coverage is generally straightforward. International patients should compare the cost of anal stretch with that of lateral internal sphincterotomy or botulinum toxin injection, as these alternatives may offer better long-term value given their more predictable outcomes and lower complication rates.

Lateral internal sphincterotomy (LIS) is the current gold standard surgical treatment for chronic anal fissures, with healing rates of 90-95% and incontinence rates of only 3-5%. The procedure involves a controlled, partial division of the internal anal sphincter through a small lateral incision. LIS provides more predictable sphincter relaxation than manual dilation and has supplanted anal stretch as the preferred surgical option at most colorectal surgery centers.

Topical pharmacological therapy is the recommended first-line treatment for chronic anal fissures. Topical glyceryl trinitrate (0.2-0.4% ointment) applied to the anal margin 2-3 times daily relaxes the internal sphincter and improves anodermal blood flow, achieving healing rates of 50-70%. Topical diltiazem (2% cream) offers similar efficacy with fewer headache side effects. Botulinum toxin injection into the internal anal sphincter provides chemical sphincterotomy, with healing rates of 60-80% and very low incontinence risk, making it an excellent option between failed topical therapy and surgery.

Conservative management including dietary fiber supplementation (25-30 g daily), adequate hydration, stool softeners, warm sitz baths, and avoidance of straining heals approximately 50% of acute anal fissures within 6-8 weeks. Fissurectomy with advancement flap is a surgical alternative that excises the chronic fissure and covers the defect with a mucosal or cutaneous advancement flap, avoiding sphincter manipulation entirely. This technique preserves sphincter integrity and is particularly useful in patients with pre-existing sphincter compromise or recurrent fissures after sphincterotomy.